Gilead asks FDA to take back lucrative orphan drug status on possible coronavirus treatment

·

·

Gilead asks FDA to take back lucrative orphan drug status on possible coronavirus treatment

(Reuters) – Gilead Sciences Inc on Wednesday took the unusual step of asking the U.S. Food and Drug Administration to rescind a controversial orphan drug designation the agency had granted for the biotech company’s potential coronavirus treatment …
See Original Article

Prisma Health collaborates with UofSC on ventilator expansion device

A collaborative effort involving Prisma Health and the University of South Carolina has resulted in emergency use authorization for a ventilator expansion device to support multiple patients during times of acute equipment shortages such as the current …
See Original Article

Micron Technology Q2 Tops Street, Outlook Strong; Shares Up 5%

(RTTNews) – Micron Technology Inc. (MU) Wednesday reported a profit for the second quarter that trumped Wall Street estimates, as did revenues. Shares of Micron gained over 5% on extended trading session after the technology company issued a strong …
See Original Article

Target Reports a 20%-Plus Rise in Comparable-Store Sales Month-to-Date

Target (NYSE: TGT) released a business update Wednesday that indicated a dramatic uptick in sales. In the press release intended to keep investors and other parties abreast of developments at the big retailer in the face of the COVID-19 coronavirus …
See Original Article

Meijer installing sneeze guards at checkouts

WALKER, Mich. — Meijer is changing the look of its checkout lanes to help protect its customers and employees during the cornavius outbreak. The Midwest retail giant will install plexiglass shields — or sneeze guards — at cash registers, beginning next …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.